Trial intelligence / Profile preview

Post-marketing surveillance of Aricept in Alzheimer's disease (ART08T)

jRCT1080222138

Sponsor
Eisai Co., Ltd.
Start
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd. Primary endpoints: Medication persistence rate with Aricept, Safety of Aricept and 1 more.

02

Drugs

donepezil
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on jRCT1080222138.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080222138.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call